Warning: The NCBI web site requires JavaScript to function. more...
Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system.
Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA.
Diabetes Technol Ther. 2009 Apr;11(4):207-10.PMID: 19344194 [PubMed - indexed for MEDLINE]Related articles
Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.
Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA.
Diabetes Care. 2009 Feb;32(2):240-4. Epub 2008 Nov 18.PMID: 19017777 [PubMed - indexed for MEDLINE]Related articlesFree article
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.
Diabetes Care. 2008 May;31(5):934-9. Epub 2008 Feb 5.PMID: 18252903 [PubMed - indexed for MEDLINE]Related articlesFree article
Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes.
Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV.
Diabetes Care. 2008 Jan;31(1):44-6. Epub 2007 Oct 1. No abstract available. PMID: 17909083 [PubMed - indexed for MEDLINE]Related articlesFree article
Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes.
Weinzimer SA, Swan KL, Sikes KA, Ahern JH.
Pediatr Diabetes. 2006 Aug;7 Suppl 4:15-9. Review.PMID: 16774613 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...